BRPI0817044A2 - Compostos de nicotinamida substituída e seu uso em medicamentos - Google Patents
Compostos de nicotinamida substituída e seu uso em medicamentosInfo
- Publication number
- BRPI0817044A2 BRPI0817044A2 BRPI0817044A BRPI0817044A2 BR PI0817044 A2 BRPI0817044 A2 BR PI0817044A2 BR PI0817044 A BRPI0817044 A BR PI0817044A BR PI0817044 A2 BRPI0817044 A2 BR PI0817044A2
- Authority
- BR
- Brazil
- Prior art keywords
- medicines
- nicotinamide compounds
- substituted nicotinamide
- substituted
- compounds
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000005480 nicotinamides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007044277A DE102007044277A1 (de) | 2007-09-17 | 2007-09-17 | Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln |
| PCT/EP2008/007633 WO2009036938A1 (de) | 2007-09-17 | 2008-09-15 | Substituierte nicotinamid-verbindungen und deren verwendung in arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0817044A2 true BRPI0817044A2 (pt) | 2015-03-24 |
Family
ID=40347805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0817044 BRPI0817044A2 (pt) | 2007-09-17 | 2008-09-15 | Compostos de nicotinamida substituída e seu uso em medicamentos |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8084470B2 (pt) |
| EP (1) | EP2188258B1 (pt) |
| JP (1) | JP5539205B2 (pt) |
| KR (1) | KR20100068453A (pt) |
| CN (1) | CN101801932A (pt) |
| AR (1) | AR068467A1 (pt) |
| BR (1) | BRPI0817044A2 (pt) |
| CA (1) | CA2699689C (pt) |
| CO (1) | CO6260092A2 (pt) |
| CY (1) | CY1113551T1 (pt) |
| DE (1) | DE102007044277A1 (pt) |
| DK (1) | DK2188258T3 (pt) |
| ES (1) | ES2400407T3 (pt) |
| HR (1) | HRP20130166T1 (pt) |
| IL (1) | IL204496A (pt) |
| MX (1) | MX2010002506A (pt) |
| NZ (1) | NZ583684A (pt) |
| PE (1) | PE20090652A1 (pt) |
| PL (1) | PL2188258T3 (pt) |
| PT (1) | PT2188258E (pt) |
| RU (1) | RU2489425C2 (pt) |
| SI (1) | SI2188258T1 (pt) |
| WO (1) | WO2009036938A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| HRP20150526T1 (hr) * | 2010-08-27 | 2015-06-19 | Grünenthal GmbH | Supstituirani 2-oksi-kinolin-3-karboksamidi kao modulatori kcnq2/3 |
| EP2630123B1 (en) * | 2010-10-20 | 2017-12-20 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| FR2968661B1 (fr) * | 2010-12-14 | 2016-01-01 | Oreal | Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones |
| US9775843B2 (en) | 2012-10-11 | 2017-10-03 | Grünenthal GmbH | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders |
| US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
| CA2892745A1 (en) | 2012-11-28 | 2014-06-05 | Grunenthal Gmbh | Specific carboxamides as kcnq2/3 modulators |
| EP3558992A4 (en) * | 2016-12-15 | 2020-12-02 | ONO Pharmaceutical Co., Ltd. | TREK CHANNEL ACTIVATOR (K + CHANNELS ASSOCIATED WITH TWIK) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
| GB9919588D0 (en) * | 1999-08-18 | 1999-10-20 | Hoechst Schering Agrevo Gmbh | Fungicidal compounds |
| EP1441722A2 (en) | 2001-02-20 | 2004-08-04 | Bristol-Myers Squibb Company | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| GB0319793D0 (en) * | 2003-08-22 | 2003-09-24 | Lilly Co Eli | Pyridinylmorpholine derivatives |
-
2007
- 2007-09-17 DE DE102007044277A patent/DE102007044277A1/de not_active Withdrawn
-
2008
- 2008-09-15 WO PCT/EP2008/007633 patent/WO2009036938A1/de active Application Filing
- 2008-09-15 HR HRP20130166AT patent/HRP20130166T1/hr unknown
- 2008-09-15 ES ES08802179T patent/ES2400407T3/es active Active
- 2008-09-15 KR KR1020107008408A patent/KR20100068453A/ko not_active Withdrawn
- 2008-09-15 BR BRPI0817044 patent/BRPI0817044A2/pt not_active IP Right Cessation
- 2008-09-15 NZ NZ583684A patent/NZ583684A/en not_active IP Right Cessation
- 2008-09-15 DK DK08802179.5T patent/DK2188258T3/da active
- 2008-09-15 PT PT88021795T patent/PT2188258E/pt unknown
- 2008-09-15 MX MX2010002506A patent/MX2010002506A/es active IP Right Grant
- 2008-09-15 CN CN200880107279A patent/CN101801932A/zh active Pending
- 2008-09-15 CA CA2699689A patent/CA2699689C/en not_active Expired - Fee Related
- 2008-09-15 SI SI200830849T patent/SI2188258T1/sl unknown
- 2008-09-15 PL PL08802179T patent/PL2188258T3/pl unknown
- 2008-09-15 RU RU2010115184/04A patent/RU2489425C2/ru not_active IP Right Cessation
- 2008-09-15 EP EP08802179A patent/EP2188258B1/de not_active Not-in-force
- 2008-09-15 JP JP2010524410A patent/JP5539205B2/ja not_active Expired - Fee Related
- 2008-09-17 PE PE2008001619A patent/PE20090652A1/es not_active Application Discontinuation
- 2008-09-17 AR ARP080104040A patent/AR068467A1/es not_active Application Discontinuation
- 2008-09-17 US US12/212,369 patent/US8084470B2/en not_active Expired - Fee Related
-
2010
- 2010-03-12 CO CO10029446A patent/CO6260092A2/es not_active Application Discontinuation
- 2010-03-15 IL IL204496A patent/IL204496A/en not_active IP Right Cessation
-
2013
- 2013-01-15 CY CY20131100043T patent/CY1113551T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008300945A1 (en) | 2009-03-26 |
| ES2400407T3 (es) | 2013-04-09 |
| EP2188258B1 (de) | 2012-11-28 |
| DE102007044277A1 (de) | 2009-03-19 |
| CO6260092A2 (es) | 2011-03-22 |
| EP2188258A1 (de) | 2010-05-26 |
| HK1144422A1 (en) | 2011-02-18 |
| AR068467A1 (es) | 2009-11-18 |
| MX2010002506A (es) | 2010-03-26 |
| PL2188258T3 (pl) | 2013-04-30 |
| CA2699689C (en) | 2015-03-24 |
| JP2010539124A (ja) | 2010-12-16 |
| CA2699689A1 (en) | 2009-03-26 |
| NZ583684A (en) | 2011-04-29 |
| CY1113551T1 (el) | 2016-06-22 |
| US8084470B2 (en) | 2011-12-27 |
| PE20090652A1 (es) | 2009-05-28 |
| RU2010115184A (ru) | 2011-10-27 |
| DK2188258T3 (da) | 2013-01-14 |
| IL204496A (en) | 2013-02-28 |
| WO2009036938A1 (de) | 2009-03-26 |
| US20090076086A1 (en) | 2009-03-19 |
| PT2188258E (pt) | 2013-01-23 |
| JP5539205B2 (ja) | 2014-07-02 |
| SI2188258T1 (sl) | 2013-01-31 |
| CN101801932A (zh) | 2010-08-11 |
| RU2489425C2 (ru) | 2013-08-10 |
| HRP20130166T1 (hr) | 2013-03-31 |
| KR20100068453A (ko) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0821027A2 (pt) | 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso | |
| BRPI1008045A2 (pt) | derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia | |
| BRPI0808098A2 (pt) | 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso | |
| BRPI0814963A2 (pt) | Pró-fármacos de dipeptóides e seu uso | |
| CY2015013I2 (el) | Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων | |
| BRPI0817881A2 (pt) | Compostos orgânicos e seus usos | |
| SMT201600258B (it) | Composto indolico e suo uso farmaceutico | |
| BRPI0813244A2 (pt) | Compostos e seus usos 708 | |
| BRPI0816372A2 (pt) | Ácidos 6-fenilnicotínicos substituídos e seu uso | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BRPI0814694A2 (pt) | novas esterases e seu uso | |
| BRPI0718182A2 (pt) | Oligorribonucleotídeos e seus usos. | |
| BRPI0814267A2 (pt) | Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico. | |
| BRPI0710878A2 (pt) | Compostos orgânicos e seus usos | |
| BRPI0810440A2 (pt) | Derivados de triazolopiridina-carboxamidas e triazolopirimidina-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica | |
| BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
| BRPI0813263A2 (pt) | Oxazolidinonas substituídas e seu uso | |
| BRPI0813947A2 (pt) | Uso de estriol em baixas doses | |
| BRPI0919810A2 (pt) | compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianos | |
| BRPI0817044A2 (pt) | Compostos de nicotinamida substituída e seu uso em medicamentos | |
| BRPI0913640A2 (pt) | substâncias policrômicas e seus usos | |
| BRPI0808846A2 (pt) | fenoxifenilamidinas 3-substituídas e seu uso como fungicidas | |
| HRP20141261T1 (xx) | Spojevi tioninija i njihove uporabe | |
| CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
| ATE493400T1 (de) | Pyridin- und pyrimidinderivate als mglur2- antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2479 DE 10-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |